Michael Fossel Michael is President of Telocyte

October 13, 2020

Age-Related Disease: Moving Toward a Cure

Filed under: Uncategorized — Tags: , , , , , , , — webmaster @ 1:36 pm

This talk describes how aging works and the prospects for curing age-related disease, including Alzheimer’s and other age-related dementias.


  1. So what you are saying is that those people with Alzheimer’s will be the first ones to to be selected for these trials andcthosecwith vascular dementia will have to wait. Is that correct? Are you close to beginning the trials or are we back to
    Where we were prior to COVID?

    Comment by Mary Beth Martinez — October 25, 2020 @ 10:56 pm

  2. Mary:

    Our primary strategic target is Alzheimer’s disease, but AD usually has a vascular component. Our approach should work equally well with either. We plan on the phase 1 FDA trial to begin in 2022. Covid has had no effect on the timing.

    Comment by webmaster — October 26, 2020 @ 8:42 am

  3. I spoke to Senator Kelly Loeffler today and told her about your trial and she asked me to send her any information on it. I know you have a specific person, who is handling the funding for this. May I have her name and what exactly would you like me to share with the senator? I have been following you since 2018 and I feel like the trial continues to be kicked down the road. My husband has vascular dementia, caused by toxic mold and I know of others, who are suffering from Alzheimer’s. I am so desperate to help and want to see this awful disease disappear. Both my parents suffered from it and numerous other friends and family members are struggling with it, as well as my husband.

    Comment by Mary Beth Martinez — October 27, 2020 @ 9:29 pm

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress